VIVI — TempraMed Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$54.87m
- CA$55.65m
- $1.84m
Annual cashflow statement for TempraMed Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1.24 | -3.25 | -3.35 | -18.2 |
| Depreciation | ||||
| Non-Cash Items | 0.014 | 1.87 | 2.16 | 14.7 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.325 | 0.842 | 0.21 | -0.156 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Payable / Accrued Expenses | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -0.873 | -0.494 | -0.941 | -3.64 |
| Capital Expenditures | -0.107 | -0.003 | 0 | -0.178 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.107 | -0.003 | 0 | -0.178 |
| Financing Cash Flow Items | 0.75 | 0 | 0 | 2.3 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.893 | 0.54 | 0.909 | 4.66 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.087 | 0.043 | -0.032 | 0.932 |